142 related articles for article (PubMed ID: 17706542)
1. Seeding drug discovery: integrating telomerase cancer biology and cellular senescence to uncover new therapeutic opportunities in targeting cancer stem cells.
Keith WN; Thomson CM; Howcroft J; Maitland NJ; Shay JW
Drug Discov Today; 2007 Aug; 12(15-16):611-21. PubMed ID: 17706542
[TBL] [Abstract][Full Text] [Related]
2. Telomerase as a therapeutic target.
Huminiecki L
Acta Biochim Pol; 1996; 43(3):531-8. PubMed ID: 8922038
[TBL] [Abstract][Full Text] [Related]
3. Telomerase and cancer: time to move from a promising target to a clinical reality.
Keith WN; Jeffry Evans TR; Glasspool RM
J Pathol; 2001 Nov; 195(4):404-14. PubMed ID: 11745671
[TBL] [Abstract][Full Text] [Related]
4. Telomerase and cancer stem cells.
Armanios M; Greider CW
Cold Spring Harb Symp Quant Biol; 2005; 70():205-8. PubMed ID: 16869755
[TBL] [Abstract][Full Text] [Related]
5. Neoplastic stem cells: a novel therapeutic target in clinical oncology.
Schulenburg A; Ulrich-Pur H; Thurnher D; Erovic B; Florian S; Sperr WR; Kalhs P; Marian B; Wrba F; Zielinski CC; Valent P
Cancer; 2006 Nov; 107(10):2512-20. PubMed ID: 17039500
[TBL] [Abstract][Full Text] [Related]
6. Telomerase targeted therapy in cancer and cancer stem cells.
Xu Y; He K; Goldkorn A
Clin Adv Hematol Oncol; 2011 Jun; 9(6):442-55. PubMed ID: 21841744
[TBL] [Abstract][Full Text] [Related]
7. G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
Huang FC; Chang CC; Lou PJ; Kuo IC; Chien CW; Chen CT; Shieh FY; Chang TC; Lin JJ
Mol Cancer Res; 2008 Jun; 6(6):955-64. PubMed ID: 18515756
[TBL] [Abstract][Full Text] [Related]
8. Nicotine-reduced endothelial progenitor cell senescence through augmentation of telomerase activity via the PI3K/Akt pathway.
Junhui Z; Xiaojing H; Binquan Z; Xudong X; Junzhu C; Guosheng F
Cytotherapy; 2009; 11(4):485-91. PubMed ID: 19499400
[TBL] [Abstract][Full Text] [Related]
9. Ligand-based vascular targeting of disease.
Rybak JN; Trachsel E; Scheuermann J; Neri D
ChemMedChem; 2007 Jan; 2(1):22-40. PubMed ID: 17154429
[TBL] [Abstract][Full Text] [Related]
10. Telomeres, senescence, and hematopoietic stem cells.
Zimmermann S; Martens UM
Cell Tissue Res; 2008 Jan; 331(1):79-90. PubMed ID: 17960423
[TBL] [Abstract][Full Text] [Related]
11. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
Li H; Zhou J; Miki J; Furusato B; Gu Y; Srivastava S; McLeod DG; Vogel JC; Rhim JS
Exp Cell Res; 2008 Jan; 314(1):92-102. PubMed ID: 17900565
[TBL] [Abstract][Full Text] [Related]
12. Targeting senescence pathways to reverse drug resistance in cancer.
Rebbaa A
Cancer Lett; 2005 Feb; 219(1):1-13. PubMed ID: 15694659
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase inhibitor p16(INK4a) and telomerase may co-modulate endothelial progenitor cells senescence.
Yang DG; Liu L; Zheng XY
Ageing Res Rev; 2008 Apr; 7(2):137-46. PubMed ID: 18343732
[TBL] [Abstract][Full Text] [Related]
14. Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies.
Keith WN; Bilsland A; Hardie M; Evans TR
Nat Clin Pract Oncol; 2004 Dec; 1(2):88-96. PubMed ID: 16264826
[TBL] [Abstract][Full Text] [Related]
15. Telomerase, senescence and ageing.
Shawi M; Autexier C
Mech Ageing Dev; 2008; 129(1-2):3-10. PubMed ID: 18215413
[TBL] [Abstract][Full Text] [Related]
16. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
17. Induction of premature senescence in human lung cancer by fungal immunomodulatory protein from Ganoderma tsugae.
Liao CH; Hsiao YM; Lin CH; Yeh CS; Wang JC; Ni CH; Hsu CP; Ko JL
Food Chem Toxicol; 2008 May; 46(5):1851-9. PubMed ID: 18329152
[TBL] [Abstract][Full Text] [Related]
18. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
Winquist RJ; Boucher DM; Wood M; Furey BF
Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
[TBL] [Abstract][Full Text] [Related]
20. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?
Sánchez-García I; Vicente-Dueñas C; Cobaleda C
Bioessays; 2007 Dec; 29(12):1269-80. PubMed ID: 18022789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
